Gujarat launches India’s first tribal focused genome sequencing initiative

Gujarat has become the first state in India to launch a large-scale genome sequencing project specifically focused on tribal communities, marking a major milestone in the nation’s efforts to combine biotechnology with inclusive public health.The initiative, led by the Gujarat Biotechnology Research Centre (GBRC), is part of a visionary plan to decode the genetic blueprint of tribal populations and develop targeted diagnostics, treatment strategies, and preventive healthcare solutions. The project operates under the broader Genome India initiative and aims to understand the growing prevalence of genetic disorders among tribal groups — a concern often linked to endogamous marriages and limited genetic diversity.
In the financial year 2025–26, the Gujarat government approved the Creation of Reference Genome Database for Tribal Population project to establish a comprehensive genomic database that bridges existing data gaps and aligns with the Department of Biotechnology’s national Genome India Project, according to information shared by the state government.Chief Minister Bhupendra Patel highlighted the deep spiritual connection between Gujarat’s Adivasi communities and nature, stating that the state’s initiative reflects both scientific progress and respect for traditional heritage. The government has also announced that 2025 will be celebrated as ‘Tribal Pride Year’ to mark the 150th birth anniversary of Bhagwan Birsa Munda, a revered symbol of tribal identity and resistance.
Gujarat’s tribal population has historically faced a higher incidence of inherited conditions such as thalassemia and sickle cell anaemia, many of which remain undetected until advanced stages. Through genome sequencing, scientists will now be able to trace genetic mutations, create low-cost diagnostic panels, and enable prenatal or embryo-level testing during IVF procedures.The project will serve as a scientific foundation for future health policies supporting the socio-economic development of tribal communities. By providing detailed genetic insights, researchers aim to enhance the detection of diseases, address issues like malnutrition and anaemia, and enable early diagnosis of genetic disorders, including Sickle Cell Anaemia and G6PD deficiency.
Research on diet, nutrition, and immunity will also be strengthened, paving the way for Precision Medicine treatments tailored to an individual’s genetic profile. For instance, genome mapping can identify carriers of the beta globin gene mutation responsible for sickle cell disease. If both parents carry the mutation, there is a 25% chance their child could develop the condition. Early detection through DNA-based panels, costing as little as Rs1,000–1,500, could replace expensive genome sequencing procedures that currently cost up to Rs1 lakh per sample.The GBRC’s sequencing capability is backed by state-of-the-art infrastructure, including three advanced genome sequencing platforms one of which features a long-read sequencer capable of analysing 5,000–10,000 base pairs, essential for identifying complex genetic mutations. These platforms, inaugurated by Chief Minister Patel, were originally used for COVID-19 genome analysis and have now been adapted for wider research applications.
In terms of operational capacity, Gujarat can sequence 25–50 genomes per run, with turnaround times ranging from 48 to 72 hours. Strategic cost management and investment in local infrastructure have reduced per-sample sequencing costs from Rs85,000 to about Rs60,000.Experts say that such studies could, in the future, allow doctors to predict how individuals will respond to specific medications, helping to prevent adverse reactions and improve treatment outcomes. With international genome projects already advancing rapidly, Gujarat’s effort represents a crucial step toward ensuring that India’s tribal communities are not left behind in the genomic revolution.

(State Correspondent)